Report cover image

Global Compounded Topical Drug Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 203 Pages
SKU # APRC20283229

Description

Summary

According to APO Research, The global Compounded Topical Drug market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Compounded Topical Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Compounded Topical Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Compounded Topical Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Compounded Topical Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Compounded Topical Drug include Triangle Compounding Pharmacy, QuVa Pharma, PharMEDium Services, Pharmaca Integrative Pharmacy, Perrigo Company plc, PCCA (Professional Compounding Centers of America), Nephron Pharmaceuticals Corporation, Medisca and Lorraine’s Pharmacy, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for Compounded Topical Drug, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Compounded Topical Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Compounded Topical Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Compounded Topical Drug revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Compounded Topical Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Compounded Topical Drug revenue, projected growth trends, production technology, application and end-user industry.

Compounded Topical Drug Segment by Company

Triangle Compounding Pharmacy
QuVa Pharma
PharMEDium Services
Pharmaca Integrative Pharmacy
Perrigo Company plc
PCCA (Professional Compounding Centers of America)
Nephron Pharmaceuticals Corporation
Medisca
Lorraine’s Pharmacy
Institutional Pharmacy Solutions
Fresenius Kabi
Fagron
Custom Scripts Pharmacy
Central Admixture Pharmacy Services (CAPS)
CareFirst Specialty Pharmacy
Cantrell Drug Company
B. Braun Melsungen AG Company
Avella Specialty Pharmacy
Atlas Pharmaceuticals
Compounded Topical Drug Segment by Type

Ointments
Lotions
Cream
Gels
Compounded Topical Drug Segment by Application

Hospitals
Retail Pharmacy
Other
Compounded Topical Drug Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Compounded Topical Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Compounded Topical Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Compounded Topical Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Compounded Topical Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Compounded Topical Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Compounded Topical Drug revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

203 Pages
1 Market Overview
1.1 Product Definition
1.2 Compounded Topical Drug Market by Type
1.2.1 Global Compounded Topical Drug Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Ointments
1.2.3 Lotions
1.2.4 Cream
1.2.5 Gels
1.3 Compounded Topical Drug Market by Application
1.3.1 Global Compounded Topical Drug Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Compounded Topical Drug Market Dynamics
2.1 Compounded Topical Drug Industry Trends
2.2 Compounded Topical Drug Industry Drivers
2.3 Compounded Topical Drug Industry Opportunities and Challenges
2.4 Compounded Topical Drug Industry Restraints
3 Global Growth Perspective
3.1 Global Compounded Topical Drug Market Perspective (2020-2031)
3.2 Global Compounded Topical Drug Growth Trends by Region
3.2.1 Global Compounded Topical Drug Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Compounded Topical Drug Market Size by Region (2020-2025)
3.2.3 Global Compounded Topical Drug Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Compounded Topical Drug Revenue by Players
4.1.1 Global Compounded Topical Drug Revenue by Players (2020-2025)
4.1.2 Global Compounded Topical Drug Revenue Market Share by Players (2020-2025)
4.1.3 Global Compounded Topical Drug Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Compounded Topical Drug Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Compounded Topical Drug Key Players Headquarters & Area Served
4.4 Global Compounded Topical Drug Players, Product Type & Application
4.5 Global Compounded Topical Drug Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Compounded Topical Drug Market CR5 and HHI
4.6.3 2024 Compounded Topical Drug Tier 1, Tier 2, and Tier 3
5 Compounded Topical Drug Market Size by Type
5.1 Global Compounded Topical Drug Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Compounded Topical Drug Revenue by Type (2020-2031)
5.3 Global Compounded Topical Drug Revenue Market Share by Type (2020-2031)
6 Compounded Topical Drug Market Size by Application
6.1 Global Compounded Topical Drug Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Compounded Topical Drug Revenue by Application (2020-2031)
6.3 Global Compounded Topical Drug Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Triangle Compounding Pharmacy
7.1.1 Triangle Compounding Pharmacy Comapny Information
7.1.2 Triangle Compounding Pharmacy Business Overview
7.1.3 Triangle Compounding Pharmacy Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.1.4 Triangle Compounding Pharmacy Compounded Topical Drug Product Portfolio
7.1.5 Triangle Compounding Pharmacy Recent Developments
7.2 QuVa Pharma
7.2.1 QuVa Pharma Comapny Information
7.2.2 QuVa Pharma Business Overview
7.2.3 QuVa Pharma Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.2.4 QuVa Pharma Compounded Topical Drug Product Portfolio
7.2.5 QuVa Pharma Recent Developments
7.3 PharMEDium Services
7.3.1 PharMEDium Services Comapny Information
7.3.2 PharMEDium Services Business Overview
7.3.3 PharMEDium Services Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.3.4 PharMEDium Services Compounded Topical Drug Product Portfolio
7.3.5 PharMEDium Services Recent Developments
7.4 Pharmaca Integrative Pharmacy
7.4.1 Pharmaca Integrative Pharmacy Comapny Information
7.4.2 Pharmaca Integrative Pharmacy Business Overview
7.4.3 Pharmaca Integrative Pharmacy Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.4.4 Pharmaca Integrative Pharmacy Compounded Topical Drug Product Portfolio
7.4.5 Pharmaca Integrative Pharmacy Recent Developments
7.5 Perrigo Company plc
7.5.1 Perrigo Company plc Comapny Information
7.5.2 Perrigo Company plc Business Overview
7.5.3 Perrigo Company plc Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.5.4 Perrigo Company plc Compounded Topical Drug Product Portfolio
7.5.5 Perrigo Company plc Recent Developments
7.6 PCCA (Professional Compounding Centers of America)
7.6.1 PCCA (Professional Compounding Centers of America) Comapny Information
7.6.2 PCCA (Professional Compounding Centers of America) Business Overview
7.6.3 PCCA (Professional Compounding Centers of America) Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.6.4 PCCA (Professional Compounding Centers of America) Compounded Topical Drug Product Portfolio
7.6.5 PCCA (Professional Compounding Centers of America) Recent Developments
7.7 Nephron Pharmaceuticals Corporation
7.7.1 Nephron Pharmaceuticals Corporation Comapny Information
7.7.2 Nephron Pharmaceuticals Corporation Business Overview
7.7.3 Nephron Pharmaceuticals Corporation Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.7.4 Nephron Pharmaceuticals Corporation Compounded Topical Drug Product Portfolio
7.7.5 Nephron Pharmaceuticals Corporation Recent Developments
7.8 Medisca
7.8.1 Medisca Comapny Information
7.8.2 Medisca Business Overview
7.8.3 Medisca Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.8.4 Medisca Compounded Topical Drug Product Portfolio
7.8.5 Medisca Recent Developments
7.9 Lorraine’s Pharmacy
7.9.1 Lorraine’s Pharmacy Comapny Information
7.9.2 Lorraine’s Pharmacy Business Overview
7.9.3 Lorraine’s Pharmacy Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.9.4 Lorraine’s Pharmacy Compounded Topical Drug Product Portfolio
7.9.5 Lorraine’s Pharmacy Recent Developments
7.10 Institutional Pharmacy Solutions
7.10.1 Institutional Pharmacy Solutions Comapny Information
7.10.2 Institutional Pharmacy Solutions Business Overview
7.10.3 Institutional Pharmacy Solutions Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.10.4 Institutional Pharmacy Solutions Compounded Topical Drug Product Portfolio
7.10.5 Institutional Pharmacy Solutions Recent Developments
7.11 Fresenius Kabi
7.11.1 Fresenius Kabi Comapny Information
7.11.2 Fresenius Kabi Business Overview
7.11.3 Fresenius Kabi Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.11.4 Fresenius Kabi Compounded Topical Drug Product Portfolio
7.11.5 Fresenius Kabi Recent Developments
7.12 Fagron
7.12.1 Fagron Comapny Information
7.12.2 Fagron Business Overview
7.12.3 Fagron Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.12.4 Fagron Compounded Topical Drug Product Portfolio
7.12.5 Fagron Recent Developments
7.13 Custom Scripts Pharmacy
7.13.1 Custom Scripts Pharmacy Comapny Information
7.13.2 Custom Scripts Pharmacy Business Overview
7.13.3 Custom Scripts Pharmacy Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.13.4 Custom Scripts Pharmacy Compounded Topical Drug Product Portfolio
7.13.5 Custom Scripts Pharmacy Recent Developments
7.14 Central Admixture Pharmacy Services (CAPS)
7.14.1 Central Admixture Pharmacy Services (CAPS) Comapny Information
7.14.2 Central Admixture Pharmacy Services (CAPS) Business Overview
7.14.3 Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.14.4 Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Product Portfolio
7.14.5 Central Admixture Pharmacy Services (CAPS) Recent Developments
7.15 CareFirst Specialty Pharmacy
7.15.1 CareFirst Specialty Pharmacy Comapny Information
7.15.2 CareFirst Specialty Pharmacy Business Overview
7.15.3 CareFirst Specialty Pharmacy Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.15.4 CareFirst Specialty Pharmacy Compounded Topical Drug Product Portfolio
7.15.5 CareFirst Specialty Pharmacy Recent Developments
7.16 Cantrell Drug Company
7.16.1 Cantrell Drug Company Comapny Information
7.16.2 Cantrell Drug Company Business Overview
7.16.3 Cantrell Drug Company Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.16.4 Cantrell Drug Company Compounded Topical Drug Product Portfolio
7.16.5 Cantrell Drug Company Recent Developments
7.17 B. Braun Melsungen AG Company
7.17.1 B. Braun Melsungen AG Company Comapny Information
7.17.2 B. Braun Melsungen AG Company Business Overview
7.17.3 B. Braun Melsungen AG Company Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.17.4 B. Braun Melsungen AG Company Compounded Topical Drug Product Portfolio
7.17.5 B. Braun Melsungen AG Company Recent Developments
7.18 Avella Specialty Pharmacy
7.18.1 Avella Specialty Pharmacy Comapny Information
7.18.2 Avella Specialty Pharmacy Business Overview
7.18.3 Avella Specialty Pharmacy Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.18.4 Avella Specialty Pharmacy Compounded Topical Drug Product Portfolio
7.18.5 Avella Specialty Pharmacy Recent Developments
7.19 Atlas Pharmaceuticals
7.19.1 Atlas Pharmaceuticals Comapny Information
7.19.2 Atlas Pharmaceuticals Business Overview
7.19.3 Atlas Pharmaceuticals Compounded Topical Drug Revenue and Gross Margin (2020-2025)
7.19.4 Atlas Pharmaceuticals Compounded Topical Drug Product Portfolio
7.19.5 Atlas Pharmaceuticals Recent Developments
8 North America
8.1 North America Compounded Topical Drug Revenue (2020-2031)
8.2 North America Compounded Topical Drug Revenue by Type (2020-2031)
8.2.1 North America Compounded Topical Drug Revenue by Type (2020-2025)
8.2.2 North America Compounded Topical Drug Revenue by Type (2026-2031)
8.3 North America Compounded Topical Drug Revenue Share by Type (2020-2031)
8.4 North America Compounded Topical Drug Revenue by Application (2020-2031)
8.4.1 North America Compounded Topical Drug Revenue by Application (2020-2025)
8.4.2 North America Compounded Topical Drug Revenue by Application (2026-2031)
8.5 North America Compounded Topical Drug Revenue Share by Application (2020-2031)
8.6 North America Compounded Topical Drug Revenue by Country
8.6.1 North America Compounded Topical Drug Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Compounded Topical Drug Revenue by Country (2020-2025)
8.6.3 North America Compounded Topical Drug Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Compounded Topical Drug Revenue (2020-2031)
9.2 Europe Compounded Topical Drug Revenue by Type (2020-2031)
9.2.1 Europe Compounded Topical Drug Revenue by Type (2020-2025)
9.2.2 Europe Compounded Topical Drug Revenue by Type (2026-2031)
9.3 Europe Compounded Topical Drug Revenue Share by Type (2020-2031)
9.4 Europe Compounded Topical Drug Revenue by Application (2020-2031)
9.4.1 Europe Compounded Topical Drug Revenue by Application (2020-2025)
9.4.2 Europe Compounded Topical Drug Revenue by Application (2026-2031)
9.5 Europe Compounded Topical Drug Revenue Share by Application (2020-2031)
9.6 Europe Compounded Topical Drug Revenue by Country
9.6.1 Europe Compounded Topical Drug Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Compounded Topical Drug Revenue by Country (2020-2025)
9.6.3 Europe Compounded Topical Drug Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Compounded Topical Drug Revenue (2020-2031)
10.2 China Compounded Topical Drug Revenue by Type (2020-2031)
10.2.1 China Compounded Topical Drug Revenue by Type (2020-2025)
10.2.2 China Compounded Topical Drug Revenue by Type (2026-2031)
10.3 China Compounded Topical Drug Revenue Share by Type (2020-2031)
10.4 China Compounded Topical Drug Revenue by Application (2020-2031)
10.4.1 China Compounded Topical Drug Revenue by Application (2020-2025)
10.4.2 China Compounded Topical Drug Revenue by Application (2026-2031)
10.5 China Compounded Topical Drug Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Compounded Topical Drug Revenue (2020-2031)
11.2 Asia Compounded Topical Drug Revenue by Type (2020-2031)
11.2.1 Asia Compounded Topical Drug Revenue by Type (2020-2025)
11.2.2 Asia Compounded Topical Drug Revenue by Type (2026-2031)
11.3 Asia Compounded Topical Drug Revenue Share by Type (2020-2031)
11.4 Asia Compounded Topical Drug Revenue by Application (2020-2031)
11.4.1 Asia Compounded Topical Drug Revenue by Application (2020-2025)
11.4.2 Asia Compounded Topical Drug Revenue by Application (2026-2031)
11.5 Asia Compounded Topical Drug Revenue Share by Application (2020-2031)
11.6 Asia Compounded Topical Drug Revenue by Country
11.6.1 Asia Compounded Topical Drug Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Compounded Topical Drug Revenue by Country (2020-2025)
11.6.3 Asia Compounded Topical Drug Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Compounded Topical Drug Revenue (2020-2031)
12.2 SAMEA Compounded Topical Drug Revenue by Type (2020-2031)
12.2.1 SAMEA Compounded Topical Drug Revenue by Type (2020-2025)
12.2.2 SAMEA Compounded Topical Drug Revenue by Type (2026-2031)
12.3 SAMEA Compounded Topical Drug Revenue Share by Type (2020-2031)
12.4 SAMEA Compounded Topical Drug Revenue by Application (2020-2031)
12.4.1 SAMEA Compounded Topical Drug Revenue by Application (2020-2025)
12.4.2 SAMEA Compounded Topical Drug Revenue by Application (2026-2031)
12.5 SAMEA Compounded Topical Drug Revenue Share by Application (2020-2031)
12.6 SAMEA Compounded Topical Drug Revenue by Country
12.6.1 SAMEA Compounded Topical Drug Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Compounded Topical Drug Revenue by Country (2020-2025)
12.6.3 SAMEA Compounded Topical Drug Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.